Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15.
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15.
复制标题
平衡:TNFSF15 调节 VEGF/VEGFR 活性。
DOI:
10.1038/s41392-018-0023-8
复制
发表时间:
2018
影响因子:
39.3
通讯作者:
Li LY
中科院分区:
文献类型:
--
作者:
Yang GL;Li LY
Vascular hyperpermeability occurs in angiogenesis and several pathobiological conditions, producing elevated interstitial fluid pressure and lymphangiogenesis. How these closely related events are modulated is a fundamentally important question regarding the maintenance of vascular homeostasis and treatment of disease conditions such as cancer, stroke, and myocardial infarction. Signals mediated by vascular endothelial growth factor receptors, noticeably VEGFR-1, −2, and −3, are centrally involved in the promotion of both blood vessel and lymphatic vessel growth. These signaling pathways are counterbalanced or, in the case of VEGFR3, augmented by signals induced by tumor necrosis factor superfamily-15 (TNFSF15). TNFSF15 can simultaneously downregulate membrane-bound VEGFR1 and upregulate soluble VEGFR1, thus changing VEGF/VEGFR1 signals from pro-angiogenic to anti-angiogenic. In addition, TNFSF15 inhibits VEGF-induced VEGFR2 phosphorylation, thereby curbing VEGFR2-mediated enhancement of vascular permeability. Third, and perhaps more interestingly, TNFSF15 is capable of stimulating VEGFR3 gene expression in lymphatic endothelial cells, thus augmenting VEGF-C/D-VEGFR3-facilitated lymphangiogenesis. We discuss the intertwining relationship between the actions of TNFSF15 and VEGF in this review. The ability of tumor necrosis factor superfamily-15 (TNFSF15) protein to balance the actions of vascular endothelial growth factors (VEGFs) highlights new therapeutic strategies for the treatment of diseases that disrupt the circulatory system. Gui-Li Yang at the Tianjin Neurological Institute and Lu-Yuan Li at Nankai University describe the mechanisms through which TNFSF15 inhibits blood vessel growth mediated by VEGF receptor-1 (VEGFR1) and counterbalances the increase in vascular permeability mediated by VEGFR2. Interestingly, TNFSF15 enhances the effects of VEGFR3 on the formation of lymphatic vessels by promoting VEGFR3 gene expression in lymphatic endothelial cells. Further research will determine whether TNFSF15′s unique capacity to regulate the properties of both blood and lymph vessels can be harnessed to improve the treatment of conditions such as cancer, stroke, myocardial infarction and lymphoedema.
登录
查看更多内容
影响因子:
2.6
作者:
Deng HT;Liu HL;Zhai BB;Zhang K;Xu GC;Peng XM;Zhang QZ;Li LY
通讯作者:
Li LY
DOI:
10.1073/pnas.041359198
发表时间:
2001-02-27
影响因子:
11.1
作者:
Fukumura, D;Gohongi, T;Jain, RK
通讯作者:
Jain, RK
影响因子:
56.9
作者:
BROOKS, PC;CLARK, RAF;CHERESH, DA
通讯作者:
CHERESH, DA
影响因子:
2.9
作者:
Gao, Weiwei;Zhao, Zilong;Zhang, Jianning
通讯作者:
Zhang, Jianning
影响因子:
5.5
作者:
Castilla, MA;Neria, F;Caramelo, C
通讯作者:
Caramelo, C